Feb 2022 – Mar 2025 · 3 yrs 1 mo · New Jersey, United States

• Oversaw communications & marketing, policy & government affairs, corporate responsibility, and organic growth. Member of agilon’s executive leadership team. Executive sponsor of the women@agilon ERG and the agilon women physician leadership council.

Aug 2021 – Feb 2022 · 6 mos · New Jersey, United States

• Oversaw all aspects of agilon health’s internal and external communications, brand and marketing strategy and execution to advance the company’s business priorities, vision and mission. Served as co-lead for the company’s ESG strategy and reporting process.

Aug 2020 – Aug 2021 · 1 yr

• Strategic lead responsible for corporate insights, communications, and influencer engagement to enhance consumer, patient and community awareness and trust in the Merck and MSD brand. Claire and her team drove forward communication and engagement strategies to advance key enterprise priorities focused on population health, patient engagement & impact, diversity & inclusion, health equity, and clinical trial diversity & recruitment. Claire served as a member of the company’s Patient Innovation Council, Diversity, Health Equity & Economic Inclusion Working Group, Access & Affordability extended leadership team, Patient Innovation & Engagement leadership team and Global Communications leadership team.

Jan 2019 – Aug 2020 · 1 yr 7 mos

• Strategic lead responsible for driving the communications and engagement strategy for Merck’s extensive human health product portfolio, pipeline and discovery engine (180+ medicines and vaccines) during a time of tremendous growth and business development activity for the company. The therapeutic business areas managed by the team included oncology, vaccines, HIV, infectious disease, immunology, cardiovascular disease, diabetes, neuroscience, women’s health, and biosimilars, among others. Co-led employee communications for the company’s Human Health commercial and marketing organization of 25,000+ employees globally. Additionally, oversaw the team executing on external and employee communications for Merck Research Laboratories and supply communications across our portfolio. Provided executive communications counsel and oversaw thought leadership for the company’s Chief Marketing Officer and Chief Medical Officer. Worked closely with investor relations and corporate functions related to the portfolio and pipeline activities. Served as a member of the Human Health extended leadership team and Global Communications leadership team. Managed a global team of 30+ employees.

Oct 2014 – Dec 2018 · 4 yrs 2 mos

• Strategic lead responsible for the external and internal communications strategy to establish the Merck as an oncology leader committed to helping cancer patients around the world. Led the launch of Keytruda,the #1 immuno-oncology therapy, and communications around the integration of several significant collaborations and acquisitions to build out the company’s oncology portfolio and pipeline. Served as a senior member of the Oncology Business Unit leadership team and executive communications counsel for the President of the Oncology Business Unit. Instrumental in establishing the company’s presence and engagement with the cancer patient advocacy community. Served in six month special assignment leading global oncology policy during this time. Managed team of 5+ employees.

Apr 2012 – Oct 2014 · 2 yrs 6 mos

• Corporate communications lead for the company’s HIV portfolio and pipeline as well as other areas of the business (i.e., neuroscience, ophthalmology). Also, served as interim lead and executive communications counsel to the President of the Hospital & Speciality Business Unit.

May 2011 – Apr 2012 · 11 mos · New York, United States

• Served as a senior counsel for broad array of healthcare clients including Janssen, Merck, Astellas, and Otsuka, among others. Led new business and served as deputy director of the healthcare practice including management of 10+ employees.

Oct 2007 – May 2011 · 3 yrs 7 mos · New York, United States

• Served as client relationship leader and senior counsel for the agency’s largest health care clients including Janssen, Amgen, Astellas, and Merck, among others. Managed team of 5+ employees.

Jun 2006 – Sep 2007 · 1 yr 3 mos · Bridgewater, New Jersey, United States

• Key member of the corporate communications & investor relations team. Led product communications and patient advocacy and supported the company’s corporate communications as well as investor relations activities. Served as the communications lead for the head of commercial. Abraxis BioScience was acquired by Celgene in 2010. Celgene was subsequently acquired by Bristol-Myers Squibb (BMS) in 2019.

Jun 2005 – Jun 2006 · 1 yr · New York, United States

• Served as an agency communications team lead in support of healthcare and corporate communications clients including Bristol-Myers Squibb (BMS).

Jan 2000 – Oct 2002 · 2 yrs 9 mos · Los Angeles, California, United States

• Worked with multiple technology, consumer, and healthcare clients conducting corporate and brand communications as well as investor relations. Worked part of the time at Feinstein Kean Healthcare in Boston.

Oct 2002 – Jun 2005 · 2 yrs 8 mos · New York, United States

• Served as a global lead for BIO’s global business development, partnering and investor relations activities with industry leaders. Developed and implemented B2B marketing strategies to drive participation key BIO conferences. Part of the team that managed BIO Annual Convention, BIO CEO & Investor Conference and BIO’s partnering/BD conferences.